Index by author

March 01, 1991; Volume 1,Issue 9

Looking for COVID information? All ASN Journal COVID articles are in the COVID-19 Research Collection or the COVID-19 In Context Collection. All articles are free.​

B

  1. Berns, J S

    1. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
      J S Berns, R M Cohen, R J Stumacher and M R Rudnick
      JASN March 1991, 1 (9) 1061-1080; DOI: https://doi.org/10.1681/ASN.V191061

  2. Brenner, B M

    1. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
      C R Bridges, H G Rennke, W M Deen, J L Troy and B M Brenner
      JASN March 1991, 1 (9) 1095-1108; DOI: https://doi.org/10.1681/ASN.V191095

  3. Bridges, C R

    1. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
      C R Bridges, H G Rennke, W M Deen, J L Troy and B M Brenner
      JASN March 1991, 1 (9) 1095-1108; DOI: https://doi.org/10.1681/ASN.V191095

C

  1. Clerch, A R

    1. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
      V Faradji-Hazan, J R Oster, D G Fedeman, A R Clerch and G O Perez
      JASN March 1991, 1 (9) 1123-1125; DOI: https://doi.org/10.1681/ASN.V191123

  2. Cohen, R M

    1. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
      J S Berns, R M Cohen, R J Stumacher and M R Rudnick
      JASN March 1991, 1 (9) 1061-1080; DOI: https://doi.org/10.1681/ASN.V191061

D

  1. Deen, W M

    1. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
      C R Bridges, H G Rennke, W M Deen, J L Troy and B M Brenner
      JASN March 1991, 1 (9) 1095-1108; DOI: https://doi.org/10.1681/ASN.V191095

  2. Drummer, C

    1. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man.
      C Drummer, F Fiedler, A König and R Gerzer
      JASN March 1991, 1 (9) 1109-1113; DOI: https://doi.org/10.1681/ASN.V191109

F

  1. Faradji-Hazan, V

    1. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
      V Faradji-Hazan, J R Oster, D G Fedeman, A R Clerch and G O Perez
      JASN March 1991, 1 (9) 1123-1125; DOI: https://doi.org/10.1681/ASN.V191123

  2. Fedeman, D G

    1. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
      V Faradji-Hazan, J R Oster, D G Fedeman, A R Clerch and G O Perez
      JASN March 1991, 1 (9) 1123-1125; DOI: https://doi.org/10.1681/ASN.V191123

  3. Fiedler, F

    1. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man.
      C Drummer, F Fiedler, A König and R Gerzer
      JASN March 1991, 1 (9) 1109-1113; DOI: https://doi.org/10.1681/ASN.V191109

G

  1. Gassman, J J

    1. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.
      A S Levey, J J Gassman, P M Hall and W G Walker
      JASN March 1991, 1 (9) 1087-1094; DOI: https://doi.org/10.1681/ASN.V191087

  2. Gerzer, R

    1. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man.
      C Drummer, F Fiedler, A König and R Gerzer
      JASN March 1991, 1 (9) 1109-1113; DOI: https://doi.org/10.1681/ASN.V191109

H

  1. Hall, P M

    1. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.
      A S Levey, J J Gassman, P M Hall and W G Walker
      JASN March 1991, 1 (9) 1087-1094; DOI: https://doi.org/10.1681/ASN.V191087

  2. Harris, H W

    1. Antidiuretic hormone modulates membrane phosphoproteins in toad urinary bladder and retrieved water channel containing apical membrane vesicles.
      H W Harris
      JASN March 1991, 1 (9) 1114-1122; DOI: https://doi.org/10.1681/ASN.V191114

  3. Humphreys, M H

    1. Urodilatin--renal natriuretic peptide?
      M H Humphreys
      JASN March 1991, 1 (9) 1057-1059; DOI: https://doi.org/10.1681/ASN.V191057

K

  1. König, A

    1. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man.
      C Drummer, F Fiedler, A König and R Gerzer
      JASN March 1991, 1 (9) 1109-1113; DOI: https://doi.org/10.1681/ASN.V191109

L

  1. Levey, A S

    1. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.
      A S Levey, J J Gassman, P M Hall and W G Walker
      JASN March 1991, 1 (9) 1087-1094; DOI: https://doi.org/10.1681/ASN.V191087

  2. Levin, N W

    1. Research on problems of the dialysis patient.
      N W Levin and G E Striker
      JASN March 1991, 1 (9) 1055-1056; DOI: https://doi.org/10.1681/ASN.V191055

M

  1. Mitch, W E

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081

N

  1. Neylan, J F

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081

O

  1. O'Brien, D P

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081

  2. Olson, R A

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081

  3. Oster, J R

    1. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
      V Faradji-Hazan, J R Oster, D G Fedeman, A R Clerch and G O Perez
      JASN March 1991, 1 (9) 1123-1125; DOI: https://doi.org/10.1681/ASN.V191123

P

  1. Perez, G O

    1. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
      V Faradji-Hazan, J R Oster, D G Fedeman, A R Clerch and G O Perez
      JASN March 1991, 1 (9) 1123-1125; DOI: https://doi.org/10.1681/ASN.V191123

R

  1. Rennke, H G

    1. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
      C R Bridges, H G Rennke, W M Deen, J L Troy and B M Brenner
      JASN March 1991, 1 (9) 1095-1108; DOI: https://doi.org/10.1681/ASN.V191095

  2. Rudnick, M R

    1. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
      J S Berns, R M Cohen, R J Stumacher and M R Rudnick
      JASN March 1991, 1 (9) 1061-1080; DOI: https://doi.org/10.1681/ASN.V191061

S

  1. Sands, J M

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081

  2. Striker, G E

    1. Research on problems of the dialysis patient.
      N W Levin and G E Striker
      JASN March 1991, 1 (9) 1055-1056; DOI: https://doi.org/10.1681/ASN.V191055

  3. Stumacher, R J

    1. Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.
      J S Berns, R M Cohen, R J Stumacher and M R Rudnick
      JASN March 1991, 1 (9) 1061-1080; DOI: https://doi.org/10.1681/ASN.V191061

T

  1. Thurau, K

    1. Remarks by the recipient of the 1990 Homer Smith Award.
      K Thurau
      JASN March 1991, 1 (9) 1060; DOI: https://doi.org/10.1681/ASN.V191060

  2. Troy, J L

    1. Reversible hexadimethrine-induced alterations in glomerular structure and permeability.
      C R Bridges, H G Rennke, W M Deen, J L Troy and B M Brenner
      JASN March 1991, 1 (9) 1095-1108; DOI: https://doi.org/10.1681/ASN.V191095

W

  1. Walker, W G

    1. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group.
      A S Levey, J J Gassman, P M Hall and W G Walker
      JASN March 1991, 1 (9) 1087-1094; DOI: https://doi.org/10.1681/ASN.V191087

  2. Whelchel, J D

    1. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation.
      J M Sands, J F Neylan, R A Olson, D P O'Brien, J D Whelchel and W E Mitch
      JASN March 1991, 1 (9) 1081-1086; DOI: https://doi.org/10.1681/ASN.V191081
Back to top

In this issue

View Selected Citations (0)